ArticleBMC cancer2022

Body mass index and serum markers associated with progression-free survival in lung cancer patients treated with immune checkpoint inhibitors.

Zhenzhen Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.